CD19 car-t cell therapy

Intervention1 paper2 findings

Associations

2

TP53

upin humans1Very low certainty

1 study

CD19 car-t cell therapy is associated with TP53 in humans.
Human trialafter CD19 CAR-T cell therapy in DLBCLbone marrow24 monthsmales
Therapy-related acute myeloid leukemia with 24-month latency after CD19 CAR-T cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a case report · Frontiers in medicine · 14 Aug 2026

Acute myeloid leukemia

upin humans1Very low certainty

1 study

CD19 car-t cell therapy is associated with acute myeloid leukemia in humans.
Human trialrelapsed/refractory diffuse large B-cell lymphoma24 monthsmales
Therapy-related acute myeloid leukemia with 24-month latency after CD19 CAR-T cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a case report · Frontiers in medicine · 14 Aug 2026

Acute myeloid leukemia →

Latest

1

Frontiers in MedicineResearch29 Aug

Therapy-related acute myeloid leukemia with 24-month latency after CD19 CAR-T cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a case report

Blood and immune system